Ohio University College of Osteopathic Medicine researchers find that elderly diabetics in extended-care facilities need improved treatment protocols for diabetes. Current standards of care fail to meet American Diabetes Association standards for outpatient diabetics.
The following is a Statement from the American College of Cardiology, American Diabetes Association and American Heart Association Related to NEJM article, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’:
The rise in diabetic cases among children in India has alarmed health experts who caution against decreasing physical activity among the children, especially of the middle class.
GlaxoSmithKline [NYSE:GSK] issued the following response to an article in the New England Journal of Medicine (NEJM) on Avandia? (rosiglitazone maleate), a widely used and highly effective treatment for type 2 diabetes:
It is known that erectile dysfunction (ED), particularly in diabetic men, is often characterized by increased oxidative stress and decreased endothelial function.
The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
Spending money to improve diabetes care at federally qualified community health centers is a sound investment, according to one of the first studies to examine the clinical and economic impact of quality improvement on diabetes care.
Higher dietary intake of fiber from grains and cereals and of magnesium may each be associated with a lower risk of type 2 diabetes, according to a report and meta-analysis in the May 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Without effective interventions, it is estimated that by the year 2030 around 3.3 million Australians will have developed type 2 diabetes.
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.